New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer

Breast cancer is a multifactor disease, and many drug combination therapies are applied for its treatment. Selenium derivatives represent a promising potential anti-breast cancer treatment. This study reports the cytotoxic activity of forty-one amides and phosphoramidates containing selenium against...

Full description

Bibliographic Details
Main Authors: Mikel Etxebeste-Mitxeltorena, Daniel Plano, Nora Astrain-Redín, Cristina Morán-Serradilla, Carlos Aydillo, Ignacio Encío, Esther Moreno, Socorro Espuelas, Carmen Sanmartín
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/4/590
_version_ 1797538055575306240
author Mikel Etxebeste-Mitxeltorena
Daniel Plano
Nora Astrain-Redín
Cristina Morán-Serradilla
Carlos Aydillo
Ignacio Encío
Esther Moreno
Socorro Espuelas
Carmen Sanmartín
author_facet Mikel Etxebeste-Mitxeltorena
Daniel Plano
Nora Astrain-Redín
Cristina Morán-Serradilla
Carlos Aydillo
Ignacio Encío
Esther Moreno
Socorro Espuelas
Carmen Sanmartín
author_sort Mikel Etxebeste-Mitxeltorena
collection DOAJ
description Breast cancer is a multifactor disease, and many drug combination therapies are applied for its treatment. Selenium derivatives represent a promising potential anti-breast cancer treatment. This study reports the cytotoxic activity of forty-one amides and phosphoramidates containing selenium against five cancer cell lines (MCF-7, CCRF-CEM, HT-29, HTB-54 and PC-3) and two nonmalignant cell lines (184B5 and BEAS-2B). MCF-7 cells were the most sensitive and the selenoamides I.1f and I.2f and the selenium phosphoramidate II.2d, with GI50 values ranging from 0.08 to 0.93 µM, were chosen for further studies. Additionally, radical scavenging activity for all the compounds was determined using DPPH and ABTS colorimetric assays. Phosphoramidates turned out to be inactive as radical scavengers. No correlation was observed for the antioxidant activity and the cytotoxic effect, except for compounds I.1e and I.2f, which showed dual antioxidant and antitumor activity. The type of programmed cell death and cell cycle arrest were determined, and the results provided evidence that I.1f and I.2f induced cell death via autophagy, while the derivative II.2d provoked apoptosis. In addition, Western blot analysis corroborated these mechanisms with an increase in Beclin1 and LC3-IIB and reduced SQSTM1/p62 levels for I.1f and I.2f, as well as an increase in BAX, p21 and p53 accompanied by a decrease in BCL-2 levels for derivative II.2d.
first_indexed 2024-03-10T12:25:03Z
format Article
id doaj.art-5d7b68a1020b47509cd0ecc3e1acf286
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T12:25:03Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-5d7b68a1020b47509cd0ecc3e1acf2862023-11-21T15:06:54ZengMDPI AGAntioxidants2076-39212021-04-0110459010.3390/antiox10040590New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast CancerMikel Etxebeste-Mitxeltorena0Daniel Plano1Nora Astrain-Redín2Cristina Morán-Serradilla3Carlos Aydillo4Ignacio Encío5Esther Moreno6Socorro Espuelas7Carmen Sanmartín8Department of Pharmaceutical Technology and Chemistry, University of Navarra, Irunlarrea 1, E-31008 Pamplona, SpainDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, Irunlarrea 1, E-31008 Pamplona, SpainDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, Irunlarrea 1, E-31008 Pamplona, SpainDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, Irunlarrea 1, E-31008 Pamplona, SpainDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, Irunlarrea 1, E-31008 Pamplona, SpainTropical Health Institute of the University of Navarra (ISTUN), University of Navarra, Irunlarrea 1, E-31008 Pamplona, SpainDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, Irunlarrea 1, E-31008 Pamplona, SpainDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, Irunlarrea 1, E-31008 Pamplona, SpainDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, Irunlarrea 1, E-31008 Pamplona, SpainBreast cancer is a multifactor disease, and many drug combination therapies are applied for its treatment. Selenium derivatives represent a promising potential anti-breast cancer treatment. This study reports the cytotoxic activity of forty-one amides and phosphoramidates containing selenium against five cancer cell lines (MCF-7, CCRF-CEM, HT-29, HTB-54 and PC-3) and two nonmalignant cell lines (184B5 and BEAS-2B). MCF-7 cells were the most sensitive and the selenoamides I.1f and I.2f and the selenium phosphoramidate II.2d, with GI50 values ranging from 0.08 to 0.93 µM, were chosen for further studies. Additionally, radical scavenging activity for all the compounds was determined using DPPH and ABTS colorimetric assays. Phosphoramidates turned out to be inactive as radical scavengers. No correlation was observed for the antioxidant activity and the cytotoxic effect, except for compounds I.1e and I.2f, which showed dual antioxidant and antitumor activity. The type of programmed cell death and cell cycle arrest were determined, and the results provided evidence that I.1f and I.2f induced cell death via autophagy, while the derivative II.2d provoked apoptosis. In addition, Western blot analysis corroborated these mechanisms with an increase in Beclin1 and LC3-IIB and reduced SQSTM1/p62 levels for I.1f and I.2f, as well as an increase in BAX, p21 and p53 accompanied by a decrease in BCL-2 levels for derivative II.2d.https://www.mdpi.com/2076-3921/10/4/590amidecytotoxicitydiselenidephosphoramidateselenocyanate
spellingShingle Mikel Etxebeste-Mitxeltorena
Daniel Plano
Nora Astrain-Redín
Cristina Morán-Serradilla
Carlos Aydillo
Ignacio Encío
Esther Moreno
Socorro Espuelas
Carmen Sanmartín
New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer
Antioxidants
amide
cytotoxicity
diselenide
phosphoramidate
selenocyanate
title New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer
title_full New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer
title_fullStr New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer
title_full_unstemmed New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer
title_short New Amides and Phosphoramidates Containing Selenium: Studies on Their Cytotoxicity and Antioxidant Activities in Breast Cancer
title_sort new amides and phosphoramidates containing selenium studies on their cytotoxicity and antioxidant activities in breast cancer
topic amide
cytotoxicity
diselenide
phosphoramidate
selenocyanate
url https://www.mdpi.com/2076-3921/10/4/590
work_keys_str_mv AT mikeletxebestemitxeltorena newamidesandphosphoramidatescontainingseleniumstudiesontheircytotoxicityandantioxidantactivitiesinbreastcancer
AT danielplano newamidesandphosphoramidatescontainingseleniumstudiesontheircytotoxicityandantioxidantactivitiesinbreastcancer
AT noraastrainredin newamidesandphosphoramidatescontainingseleniumstudiesontheircytotoxicityandantioxidantactivitiesinbreastcancer
AT cristinamoranserradilla newamidesandphosphoramidatescontainingseleniumstudiesontheircytotoxicityandantioxidantactivitiesinbreastcancer
AT carlosaydillo newamidesandphosphoramidatescontainingseleniumstudiesontheircytotoxicityandantioxidantactivitiesinbreastcancer
AT ignacioencio newamidesandphosphoramidatescontainingseleniumstudiesontheircytotoxicityandantioxidantactivitiesinbreastcancer
AT esthermoreno newamidesandphosphoramidatescontainingseleniumstudiesontheircytotoxicityandantioxidantactivitiesinbreastcancer
AT socorroespuelas newamidesandphosphoramidatescontainingseleniumstudiesontheircytotoxicityandantioxidantactivitiesinbreastcancer
AT carmensanmartin newamidesandphosphoramidatescontainingseleniumstudiesontheircytotoxicityandantioxidantactivitiesinbreastcancer